Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads. - Vagolu Siva Krishna; Shan Zheng; Estharla Madhu Rekha; Luke W. Guddat; Dharmarajan Sriram (J. Comput. Aided Mol. Des., 2019)